GLAXOSMITHKLINE FDA Approval NDA 050167

NDA 050167

GLAXOSMITHKLINE

FDA Drug Application

Application #050167

Application Sponsors

NDA 050167GLAXOSMITHKLINE

Marketing Status

Discontinued002

Application Products

002AEROSOL;TOPICAL10,000 UNITS/GM;2,000,000 UNITS/GM0POLYSPORINBACITRACIN ZINC; POLYMYXIN B SULFATE

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50167
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"POLYSPORIN","activeIngredients":"BACITRACIN ZINC; POLYMYXIN B SULFATE","strength":"10,000 UNITS\/GM;2,000,000 UNITS\/GM","dosageForm":"AEROSOL;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"POLYSPORIN","submission":"BACITRACIN ZINC; POLYMYXIN B SULFATE","actionType":"10,000 UNITS\/GM;2,000,000 UNITS\/GM","submissionClassification":"AEROSOL;TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.